Skip to main content
Erschienen in: Archives of Dermatological Research 3/2023

25.05.2022 | Original Paper

Investigating the epidemiological relationship between vitiligo and psoriasis: a population-based study

verfasst von: Khalaf Kridin, Keren Lyakhovitsky, Erez Onn, Anna Lyakhovitsky, Ralf Ludwig, Orly Weinstein, Arnon D. Cohen

Erschienen in: Archives of Dermatological Research | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

The association of vitiligo with psoriasis is inconsistent in the current literature.

Objective

To assess the bidirectional association between vitiligo and psoriasis.

Methods

A population-based study was performed to compare vitiligo patients (n = 20,851) with age-, sex- and ethnicity-matched control subjects (n = 102,475) regarding the incidence of new-onset and the prevalence of preexisting psoriasis. Adjusted hazard ratios (HRs) and adjusted odds ratios (ORs) were calculated by cox regression and logistic regression, respectively.

Results

The incidence rate of new-onset psoriasis was estimated at 7.9 (95% CI 6.4–9.7) and 4.7 (95% CI 4.1–5.3) cases per 10,000 person-years among patients with vitiligo and controls, respectively. Patients with vitiligo experienced an increased risk of psoriasis (fully-adjusted HR 1.71; 95% CI 1.35–2.17; P < 0.001). On the other hand, the odds of vitiligo were only marginally elevated among patients with preexisting psoriasis (fully-adjusted OR 1.19; 95% CI 1.01–1.40; P = 0.051). Compared to other patients with vitiligo, those with vitiligo and comorbid psoriasis were older at the onset of the disease and had a greater prevalence of metabolic and cardiovascular comorbidities.

Conclusions

A diagnosis of vitiligo predisposes individuals to develop subsequent psoriasis. Clinicians managing dermatologic patients ought to be aware of this comorbidity. Further research is required to explicate the pathomechanism underlying this epidemiological observation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Speeckaert R, van Geel N (2017) Vitiligo: an update on pathophysiology and treatment options. Am J Clin Dermatol 18:733–744CrossRefPubMed Speeckaert R, van Geel N (2017) Vitiligo: an update on pathophysiology and treatment options. Am J Clin Dermatol 18:733–744CrossRefPubMed
2.
Zurück zum Zitat Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE (2017) New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol 77(1):1–13CrossRefPubMed Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE (2017) New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol 77(1):1–13CrossRefPubMed
3.
4.
Zurück zum Zitat Bassiouny DA, Shaker O (2011) Role of interleukin-17 in the pathogenesis of vitiligo. Clin Exp Dermatol 36:292–297CrossRefPubMed Bassiouny DA, Shaker O (2011) Role of interleukin-17 in the pathogenesis of vitiligo. Clin Exp Dermatol 36:292–297CrossRefPubMed
5.
Zurück zum Zitat Dahir AM, Thomsen SF (2018) Comorbidities in vitiligo: comprehensive review. Int J Dermatol 57:1157–1164CrossRefPubMed Dahir AM, Thomsen SF (2018) Comorbidities in vitiligo: comprehensive review. Int J Dermatol 57:1157–1164CrossRefPubMed
6.
Zurück zum Zitat Armstrong AW, Read C (2020) Pathophysiology, clinical presentation, and treatment of psoriasis: a review. J Am Med Assoc 323:1945–1960CrossRef Armstrong AW, Read C (2020) Pathophysiology, clinical presentation, and treatment of psoriasis: a review. J Am Med Assoc 323:1945–1960CrossRef
8.
Zurück zum Zitat Michalek IM, Loring B, John SM (2017) A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol 31:205–212CrossRefPubMed Michalek IM, Loring B, John SM (2017) A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol 31:205–212CrossRefPubMed
9.
Zurück zum Zitat Di Cesare A, Di Meglio P, Nestle FO (2009) The IL-23Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129:1339–1350CrossRefPubMed Di Cesare A, Di Meglio P, Nestle FO (2009) The IL-23Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129:1339–1350CrossRefPubMed
10.
Zurück zum Zitat Wu JJ, Nguyen TU, Poon KYT, Herrinton LJ (2012) The association of psoriasis with autoimmune diseases. J Am Acad Dermatol 67:924–930CrossRefPubMed Wu JJ, Nguyen TU, Poon KYT, Herrinton LJ (2012) The association of psoriasis with autoimmune diseases. J Am Acad Dermatol 67:924–930CrossRefPubMed
11.
Zurück zum Zitat Zhu KJ, Lv YM, Yin XY, Wang ZX, Sun LD, He SM et al (2011) Psoriasis regression analysis of MHC loci identifies shared genetic variants with vitiligo. PLoS ONE 6:e23089CrossRefPubMedPubMedCentral Zhu KJ, Lv YM, Yin XY, Wang ZX, Sun LD, He SM et al (2011) Psoriasis regression analysis of MHC loci identifies shared genetic variants with vitiligo. PLoS ONE 6:e23089CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Yen H, Chi CC (2019) Association between psoriasis and vitiligo: a systematic review and meta-analysis. Am J Clin Dermatol 20:31–40CrossRefPubMed Yen H, Chi CC (2019) Association between psoriasis and vitiligo: a systematic review and meta-analysis. Am J Clin Dermatol 20:31–40CrossRefPubMed
14.
Zurück zum Zitat Teulings HE, Ceylan E, Overkamp M, Vrijman C, Bos JD, Nijsten TE et al (2016) Nonsegmental vitiligo disease duration and female sex are associated with comorbidity and disease extent: a retrospective analysis in 1307 patients aged ≥ 50 years. Br J Dermatol 175:821–824CrossRefPubMed Teulings HE, Ceylan E, Overkamp M, Vrijman C, Bos JD, Nijsten TE et al (2016) Nonsegmental vitiligo disease duration and female sex are associated with comorbidity and disease extent: a retrospective analysis in 1307 patients aged ≥ 50 years. Br J Dermatol 175:821–824CrossRefPubMed
15.
Zurück zum Zitat Arunachalam M, Dragoni F, Colucci R, Berti S, Crocetti E, Galeone M et al (2014) Non-segmental vitiligo and psoriasis comorbidity—a case–control study in italian patients. J Eur Acad Dermatol Venereol 28:433–437CrossRefPubMed Arunachalam M, Dragoni F, Colucci R, Berti S, Crocetti E, Galeone M et al (2014) Non-segmental vitiligo and psoriasis comorbidity—a case–control study in italian patients. J Eur Acad Dermatol Venereol 28:433–437CrossRefPubMed
16.
Zurück zum Zitat Prignano F, Pescitelli L, Ricceri F, Lotti T (2008) The importance of genetical link in immuno-mediated dermatoses: psoriasis and vitiligo. Int J Dermatol 47:1060–1062CrossRefPubMed Prignano F, Pescitelli L, Ricceri F, Lotti T (2008) The importance of genetical link in immuno-mediated dermatoses: psoriasis and vitiligo. Int J Dermatol 47:1060–1062CrossRefPubMed
17.
18.
Zurück zum Zitat Lee H, Lee MH, Lee DY, Kang HY, Kim KH, Choi GS et al (2015) Prevalence of vitiligo and associated comorbidities in korea. Yonsei Med J 56:719–725CrossRefPubMedPubMedCentral Lee H, Lee MH, Lee DY, Kang HY, Kim KH, Choi GS et al (2015) Prevalence of vitiligo and associated comorbidities in korea. Yonsei Med J 56:719–725CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Chen YT, Chen YJ, Hwang CY, Lin MW, Chen TJ, Chen CC et al (2015) Comorbidity profiles in association with vitiligo: a nationwide population-based study in taiwan. J Eur Acad Dermatol Venereol 29:1362–1369CrossRefPubMed Chen YT, Chen YJ, Hwang CY, Lin MW, Chen TJ, Chen CC et al (2015) Comorbidity profiles in association with vitiligo: a nationwide population-based study in taiwan. J Eur Acad Dermatol Venereol 29:1362–1369CrossRefPubMed
21.
Zurück zum Zitat Sawchuk M, Spano F, Loo WJ, Guenther L (2012) The coexistence of psoriasis and vitiligo: a review. J Cutan Med Surg 16:300–305CrossRefPubMed Sawchuk M, Spano F, Loo WJ, Guenther L (2012) The coexistence of psoriasis and vitiligo: a review. J Cutan Med Surg 16:300–305CrossRefPubMed
22.
Zurück zum Zitat Canu D, Shourick J, Andreu N, Gey A, Ballanger-Désolneux F, Barailler H et al (2021) Demographic and clinical characteristics of patients with both psoriasis and vitiligo in a cohort of vitiligo patients: a cross-sectional study. J Eur Acad Dermatol Venereol. https://doi.org/10.1111/jdv.17383CrossRefPubMed Canu D, Shourick J, Andreu N, Gey A, Ballanger-Désolneux F, Barailler H et al (2021) Demographic and clinical characteristics of patients with both psoriasis and vitiligo in a cohort of vitiligo patients: a cross-sectional study. J Eur Acad Dermatol Venereol. https://​doi.​org/​10.​1111/​jdv.​17383CrossRefPubMed
23.
Zurück zum Zitat Greenland S, Thomas DC (1982) On the need for the rare disease assumption in case-control studies. Am J Epidemiol 116:547–553CrossRefPubMed Greenland S, Thomas DC (1982) On the need for the rare disease assumption in case-control studies. Am J Epidemiol 116:547–553CrossRefPubMed
24.
Zurück zum Zitat Kridin K, Ludwig RJ, Schonmann Y, Damiani G, Cohen AD (2020) The bidirectional association between bullous pemphigoid and psoriasis: a population-based cohort study. Front Med 7:511CrossRef Kridin K, Ludwig RJ, Schonmann Y, Damiani G, Cohen AD (2020) The bidirectional association between bullous pemphigoid and psoriasis: a population-based cohort study. Front Med 7:511CrossRef
25.
Zurück zum Zitat Cohen AD, Dreiher J, Regev-Rosenberg S, Yakovson O, Lieberman N, Goldfracht M et al (2010) The quality indigators program in clalit health services: the first decade. Harefuah 149:204–209PubMed Cohen AD, Dreiher J, Regev-Rosenberg S, Yakovson O, Lieberman N, Goldfracht M et al (2010) The quality indigators program in clalit health services: the first decade. Harefuah 149:204–209PubMed
26.
Zurück zum Zitat Singh S, Young P, Armstrong AW (2017) An update on psoriasis and metabolic syndrome: a meta-analysis of observational studies. PLoS ONE 12:e0181039CrossRefPubMedPubMedCentral Singh S, Young P, Armstrong AW (2017) An update on psoriasis and metabolic syndrome: a meta-analysis of observational studies. PLoS ONE 12:e0181039CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Selenyi A (1955) Vitiligo and psoriasis on the same side with syringomyelia. Borgyogy Venerol Sz Hungr 9:94–96 Selenyi A (1955) Vitiligo and psoriasis on the same side with syringomyelia. Borgyogy Venerol Sz Hungr 9:94–96
28.
29.
Zurück zum Zitat Chan LS, Vanderlugt CJ, Hashimoto T, Nishikawa T, Zone JJ, Black MM et al (1998) Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol 110:103–109CrossRefPubMed Chan LS, Vanderlugt CJ, Hashimoto T, Nishikawa T, Zone JJ, Black MM et al (1998) Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol 110:103–109CrossRefPubMed
30.
Zurück zum Zitat Fain PR, Gowan K, LaBerge GS, Alkhateeb A, Stetler GL, Talbert J et al (2003) A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci. Am J Hum Genet 72:1560–1564CrossRefPubMedPubMedCentral Fain PR, Gowan K, LaBerge GS, Alkhateeb A, Stetler GL, Talbert J et al (2003) A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci. Am J Hum Genet 72:1560–1564CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Das D, Akhtar S, Kurra S, Gupta S, Sharma A (2019) Emerging role of immune cell network in autoimmune skin disorders: an update on pemphigus, vitiligo and psoriasis. Cytokine Growth Factor Rev 45:35–44CrossRefPubMed Das D, Akhtar S, Kurra S, Gupta S, Sharma A (2019) Emerging role of immune cell network in autoimmune skin disorders: an update on pemphigus, vitiligo and psoriasis. Cytokine Growth Factor Rev 45:35–44CrossRefPubMed
33.
Zurück zum Zitat Seneschal J, Boniface K, D’Arino A, Picardo M (2021) An update on vitiligo pathogenesis. Pigment Cell Melanoma Res 34:236–243CrossRefPubMed Seneschal J, Boniface K, D’Arino A, Picardo M (2021) An update on vitiligo pathogenesis. Pigment Cell Melanoma Res 34:236–243CrossRefPubMed
Metadaten
Titel
Investigating the epidemiological relationship between vitiligo and psoriasis: a population-based study
verfasst von
Khalaf Kridin
Keren Lyakhovitsky
Erez Onn
Anna Lyakhovitsky
Ralf Ludwig
Orly Weinstein
Arnon D. Cohen
Publikationsdatum
25.05.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Dermatological Research / Ausgabe 3/2023
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-022-02358-8

Weitere Artikel der Ausgabe 3/2023

Archives of Dermatological Research 3/2023 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Isotretinoin: Risiko für schwere Laboranomalien „marginal erhöht“

08.05.2024 Akne Nachrichten

Die Aknetherapie mit Isotretinoin kann einen Anstieg von Leberenzymen und Blutfetten verursachen. Das Risiko für schwere Störungen ist laut einer Forschungsgruppe der Universität Lübeck aber nur marginal erhöht und auf einen engen Zeitraum konzentriert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.